EUCTR2004-001485-41-ES进行中（未招募）不适用
A single-blinded assessment of the short-term effects of cabergoline vs. carbidopa/levodopa on SPECT dopamine transporter density in out-patient subjects with Parkinson’s Disease
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 120
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •(a)The subject is aged 40 years or older.
- •(b)Written informed consent is obtained.
- •(c)Subjects have a diagnosis of idiopathic Parkinson’s disease.
- •(d)Hoehn and Yahr stages for subjects are I-II.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years)
- •F.1.3.1 Number of subjects for this age range
排除标准
- •(a)The subject has atypical or drug-induced Parkinson’s disease.
- •(b)The subject has dementia.
- •(c)The subject has clinically significant abnormal laboratory values, and/or clinically significant or unstable medical or psychiatric illness.
- •(d)The subject is pregnant.
- •(e)The subject has a history of alcohol, narcotic, or any other drug abuse as defined by the Diagnostic and Statistical Manual of the American Psychiatric Association, 4th Edition (DSM IV) {American Psychiatric Association, 1994 #2}within the past 2 years.
- •(f)The subject has received an investigational drug within 30 days before the screening visit.
- •(g)The subject has been treated with any anti-Parkinson drug including levodopa, dopamine agonists (including pramipexole, ropinirole, cabergoline, pergolide), amantadine, selegeline, rasagiline for greater than a total of 14 days or at any time within 60 days of the baseline visit.
- •(h)The subject has used any prescription or clinically significant over-the-counter (OTC) drugs disallowed by the protocol (anticholinergic drugs, dopamine antagonists, or antihistamines as identified in section 6) within 14 (60 days for antiparkinson’s agents) days before the baseline visit.
研究者
相似试验
进行中（未招募）
不适用
A single-blinded assessment of the short-term effects of cabergoline vs. carbidopa/levodopa on SPECT dopamine transporter density in out-patient subjects with Parkinson’s Disease - N/AEUCTR2004-001485-41-ATInstitute for Neurodegenerative Disorders120
进行中（未招募）
不适用
A single-blinded assessment of the short-term effects of cabergoline vs. carbidopa/levodopa on SPECT dopamine transporter density in out-patient subjects with Parkinson’s Disease - N/AApproximately 120 recently diagnosed/early Parkinson’s disease subjects, who are untreated (see exclusionary criteria).EUCTR2004-001485-41-GBInstitute for Neurodegenerative Disorders120
尚未招募
4 期
A study to check the effect of wound dressing in long standing wounds of legCTRI/2023/02/049571Dr Sanjay Sharma
已完成
不适用
A single-blind cross-over study examining the effects of heated humidification to nasopharynx on snoring and self-reported sleep quality in healthy adultHabitual snoringJPRN-UMIN000025380Second Department of Internal Medicine, Nara Medical University30
已完成
Unknown
Effectiveness of Plum clear moisture gel cream in skin blemishesCTRI/2024/01/061140Pureplay Skin Sciences India Pvt Ltd